Investigating the roles of LynA and LynB kinases in immune signaling related to lupus
Official title: Functions of LynA and LynB kinases in dendritic-cell pro-inflammatory signaling and lupus
Funded at University of Minnesota · NIH-11141294 · Data updated 2026-11-12
This study is looking at two types of a protein called Lyn to see how they affect the immune system and their role in lupus, with the hope that what we learn could help create better treatments for people with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | September 20, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $300,000 |
| NIH project number | 1R56AR084525-01 |
| Project ID | NIH-11141294 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with systemic lupus erythematosus or those with a family history of autoimmune diseases.
✕Less likely to help
Patients with autoimmune conditions unrelated to lupus or those without any autoimmune diseases may not benefit from this research.
What this research studies
This research explores how two forms of the Lyn kinase, LynA and LynB, affect immune responses and their connection to systemic lupus erythematosus (SLE). By studying genetically modified mice, the researchers aim to understand the distinct functions of these kinases in regulating inflammation and autoimmunity. The study will also investigate how changes in the expression of these kinases can influence immune signaling pathways, potentially leading to new therapeutic strategies for lupus. Patients may benefit from insights gained about the immune system's regulation and the development of targeted treatments.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that better manage or prevent lupus and other autoimmune diseases.
How similar studies have gone: Previous research has shown that targeting specific immune signaling pathways can lead to significant advancements in treating autoimmune diseases, suggesting this approach may also yield valuable insights.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Freedman, Tanya S. — University of Minnesota
- Study coordinator: Freedman, Tanya S.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how DIS3L2 helps keep RNA in check to help lupus patients
A physician-scientist team is studying how a watchdog molecule for RNA (DIS3L2) may drive lupus-related immune problems, with the goal of uncovering new paths to treatment.
-
Pathogenic T cells in discoid lupus erythematosus
A doctor-scientist at Yale is studying why certain immune T cells cause skin damage in discoid lupus, with the goal of finding ways to reduce scarring and improve health for patients, especially African American women.
-
Glycoprotein urine markers that signal lupus nephritis treatment response
A novel test uses urine glycoprotein patterns to show how well lupus nephritis is responding to standard treatment.
-
Immunostimulatory short non-coding RNAs and lupus
A study in people with lupus looks at tiny RNA pieces that may spark inflammation, to understand if they drive disease activity.
-
Antiviral factors that limit HIV in people with SLE
Researchers at Howard University are studying how immune factors in people with lupus may help limit HIV infection.
-
PTPRS and lupus nephritis: a new target to reduce kidney damage in lupus
Aims to understand how PTPRS contributes to kidney inflammation and scarring in lupus nephritis and explore targeting it to help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.